Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardlytics, Inc. - Common Stock (NQ:CDLX)

1.480 +0.080 (+5.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 772,665
Open 1.380
Bid (Size) 1.290 (38)
Ask (Size) 1.500 (5)
Prev. Close 1.400
Today's Range 1.330 - 1.480
52wk Range 1.220 - 15.89
Shares Outstanding 33,040,112
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Which stocks are moving after the closing bell on Tuesday?
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill

Performance

YTD
-60.3%
-60.3%
1 Month
-28.5%
-28.5%
3 Month
-50.2%
-50.2%
6 Month
-60.7%
-60.7%
1 Year
-89.1%
-89.1%

More News

Read More
Law Offices of Frank R. Cruz Encourages Cardlytics, Inc. (CDLX) Investors To Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
From Faruqi & Faruqi LLP
Via GlobeNewswire
CDLX INVESTORS: Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the Class Action Against Cardlytics, Inc.
From Robbins LLP
Via GlobeNewswire
12 Communication Services Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Communication Services Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Cardlytics Announces Fourth Quarter and Full Year 2024 Financial Results
From Cardlytics, Inc.
Via Business Wire
Earnings Scheduled For March 12, 2025
Via Benzinga
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
From Faruqi & Faruqi LLP
Via GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cardlytics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Faruqi & Faruqi Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX
From Faruqi & Faruqi LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Block, and Crocs and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
From Faruqi & Faruqi LLP
Via GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cardlytics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Cardlytics, Inc.
Via Business Wire
Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2024 Earnings Release
From Cardlytics, Inc.
Via Business Wire
Law Offices of Howard G. Smith Encourages Cardlytics, Inc. (CDLX) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
From Faruqi & Faruqi LLP
Via GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cardlytics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cardlytics, Novo Nordisk, Micron, and ModivCare and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cardlytics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Cardlytics, Inc. (NASDAQ: CDLX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
From DiCello Levitt LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Block, and Crocs and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is Cardlytics, Inc. - Common Stock publicly traded?
Yes, Cardlytics, Inc. - Common Stock is publicly traded.
What exchange does Cardlytics, Inc. - Common Stock trade on?
Cardlytics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cardlytics, Inc. - Common Stock?
The ticker symbol for Cardlytics, Inc. - Common Stock is CDLX on the Nasdaq Stock Market
What is the current price of Cardlytics, Inc. - Common Stock?
The current price of Cardlytics, Inc. - Common Stock is 1.480
When was Cardlytics, Inc. - Common Stock last traded?
The last trade of Cardlytics, Inc. - Common Stock was at 04/11/25 04:00 PM ET
What is the market capitalization of Cardlytics, Inc. - Common Stock?
The market capitalization of Cardlytics, Inc. - Common Stock is 48.90M
How many shares of Cardlytics, Inc. - Common Stock are outstanding?
Cardlytics, Inc. - Common Stock has 49M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.